Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TERAZOSIN for Benign prostatic hyperplasia: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 61 adverse event reports in the FDA FAERS database where TERAZOSIN was used for Benign prostatic hyperplasia.

Most Reported Side Effects for TERAZOSIN

Side Effect Reports % Deaths Hosp.
Therapeutic product effect incomplete 75 14.1% 0 57
Asthma 66 12.4% 0 49
Dyspnoea 60 11.3% 1 33
Drug ineffective 56 10.6% 0 15
Dizziness 47 8.9% 1 14
Cough 46 8.7% 1 25
Chest pain 42 7.9% 0 41
Malaise 40 7.5% 0 11
Hospitalisation 37 7.0% 0 37
Drug hypersensitivity 36 6.8% 0 2
Hypotension 36 6.8% 0 16
Pain 34 6.4% 0 10
Bradycardia 30 5.7% 0 20
Chest discomfort 29 5.5% 0 9
Product use issue 29 5.5% 0 10

Other Indications for TERAZOSIN

Product used for unknown indication (210) Hypertension (88) Prostatomegaly (12) Prostatic disorder (11) Blood pressure measurement (10) Secondary hypertension (9) Prostatic adenoma (7) Blood pressure abnormal (5)

Other Drugs Used for Benign prostatic hyperplasia

TAMSULOSIN (3,156) TADALAFIL (1,154) FINASTERIDE (1,104) DUTASTERIDE (1,004) ALFUZOSIN (849) SILODOSIN (628) DUTASTERIDE\TAMSULOSIN (313) DOXAZOSIN (219) HERBALS\SAW PALMETTO (181) MIRABEGRON (93)

Related Pages

TERAZOSIN Full Profile All Benign prostatic hyperplasia Drugs TERAZOSIN Demographics TERAZOSIN Timeline